A clinical evaluation of Siddha herbal formulation Panchathaarai kuzhambu (Internal medicine) and Ottrai thalaivali thylam (External medicine) in the management of Ottrai thalaivali (Migraine)
Abstract
Migraine is a syndrome of headache which is benign and re-occurring, along with various neurological dysfunctions, nausea/vomiting etc, affecting about 20% of females and 6% of males at some point in life. It affects over one billion people worldwide. According to Siddha, Ottrai thalaivali (migraine) is characterized as unilateral headache, lacrimation, irritability, sighing, fatigue, tremor, startling, loss of appetite and tingling sensation. Research studies regarding Migraine was searched in databases like PubMed, Google scholar, scopus, web of science, using keywords Migraine and siddha, Migraine AND Panchathaarai kuzhambu, Ottrai thalaivali and Clinical trial. Eventhough, there are a few papers proving the effectiveness of ayurvedic treatment regimens for migraine, No works have been found relating siddha clinical trials and migraine. Also as the disease requires long term management, there is a need to look for herbal formulations that can be effective in the management of Migraine. The herbal formulations Panchathaarai kuzhambu and Ottrai thalaivali thylam have been taken for the study to prove its effectiveness on Migraine. A Clinical trial was conducted on 10 patients diagnosed with Ottrai thalaivali(Migraine). The trial drugs Panchathaarai kuzhambu was given in a dose of 2gms twice daily along with cow’s milk and Ottrai thalaivali, 70ml as bath oil twice in a week, given for 48 days. The results using HIT-6 Score and Headache diary showed that there was significant…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.